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Ste7p and Mkk1p are MEK (MAPK/ERK kinase) family members that function in the mating and cell
integrity signal transduction pathways in Saccharomyces cerevisiae. We selected STE7 andMKK1mutations that
stimulated their respective pathways in the absence of an inductive signal. Strikingly, serine-to-proline sub-
stitutions at analogous positions in Ste7p (position 368) and Mkk1p (position 386) were recovered by inde-
pendent genetic screens. Such an outcome suggests that this substitution in other MEKs would exhibit similar
properties. The Ste7p-P368 variant has higher basal enzymatic activity than Ste7p but still requires induction
to reach full activation. The higher activity associated with Ste7p-P368 allows it to compensate for defects in the
cell integrity pathway, but it does so only when it is overproduced or when Ste5p is missing. This behavior sug-
gests that Ste5p, which has been proposed to be a tether for the kinases in the mating pathway, contributes to
Ste7p specificity.
Extracellular molecules that regulate cell proliferation and
differentiation in eukaryotes depend on pathways that detect
signals at the cell surface and transmit them through the cyto-
plasm to nuclear and other intracellular targets. One mecha-
nism for transmitting these signals involves a phosphorylation
cascade that is conserved in organisms as diverse as Saccharo-
myces cerevisiae and humans. The three sequentially acting
enzymes of the conserved cascade are called MEK kinases
(MEKKs), MAPK/ERK kinases (MEKs), and mitogen-acti-
vated protein kinases (MAPKs).
Presently, there is evidence for five separate but structurally
related MAPK activation pathways that mediate distinct re-
sponses to different extracellular or cell autonomous signals in
the budding yeast S. cerevisiae (for a review, see reference 33).
Two of these pathways figure prominently in the work de-
scribed here (Fig. 1). One controls the mating response, in
which pheromones inform cells of the proximity of a mating
partner and induce differentiation into a mating-competent
state. The second regulates cell wall construction, a process
that is especially important at regions of polarized growth
during cell proliferation or mating differentiation (11, 32, 40).
Activation of the mating response pathway occurs when the
peptide pheromone secreted by one cell type binds to the
specific integral membrane receptor on the opposite cell type
(Fig. 1). This cell surface interaction stimulates the dissociation
of a heterotrimeric G protein into its Gbg and Ga subunits.
Free Gbg stimulates a phosphorylation cascade composed of
protein kinases that function in the order Ste20p, Ste11p,
Ste7p, and Fus3p/Kss1p (for a review, see reference 13). The
mechanisms underlying activation of Ste20p and Ste11p are
still not known. However, Ste7p is directly phosphorylated and
activated by Ste11p (40). The activation of Ste7p appears to
involve two residues (Ser-359 and Thr-363) which are located
in a region analogous to the phosphorylation lip of MAPK (17,
40, 63). Ste7p activates Fus3p and Kss1p by phosphorylating
them at the Thr and Tyr residues of the signature TEY motif
within the MAPK phosphorylation lip (12, 16). Fus3p and
Kss1p are redundant for pheromone-induced signal transmis-
sion leading to transcriptional activation of genes whose prod-
ucts are required for the process of mating (9). Fus3p has an
additional role in promoting arrest of the cell cycle at the G1
phase (43, 57).
Ste5p is also essential for mating competence and transmis-
sion of the pheromone-induced signal, but until recently, its
molecular function has been enigmatic (21, 34). Deductions
from genetic epistasis analyses place its first execution point
after the G protein and before or at the level of Ste11p (for a
review, see reference 13). However, results from two-hybrid
analyses showed that Ste5p interacts with Ste11p, Ste7p,
Kss1p, and Fus3p. The multiple interactions are consistent
with Ste5p having a role in several steps along the MAPK
activation pathway (3, 44, 36). Additional biochemical evi-
dence showed that Ste5p and these four kinases are present in
a macromolecular assembly (3). These findings suggest a
model in which Ste5p is a scaffold that promotes interactions
between the kinases in the mating response pathway.
The phosphorylation cascade that is part of the cell integrity
pathway includes Pkc1p (the yeast protein kinase C homolog),
Bck1p (a MEKK), the redundant Mkk1p and Mkk2p enzymes
(MEKs), and Mpk1p (a MAPK) (Fig. 1). Genetic approaches
identified these components and established their order of
function (13). The finding that Pkc1p phosphorylates Bck1p in
vitro provides biochemical corroboration for the relationship
between these two components (58).
Only more recently has there been evidence for multiple
MAPK activation pathways in vertebrates (8). One pathway
mediates responses to mitogenic agents and uses Raf-1, Mek1,
and Mek2 and the p42 and p44 MAPK isozymes (37). A more
recently identified pathway mediates stress responses to agents
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such as UV and tumor necrosis factor alpha. This pathway uses
Mekk1, a mammalian MEKK family member; a MEK family
member called Sek1 or JNKK1; and a MAPK family member
called Sapk1 or JNK1 (39, 47, 60). Raf-1 and Mekk1 activate
Mek1 and Sek1, respectively, by phosphorylating two serine
residues that are analogous to the Ser-359 and Thr-363 resi-
dues implicated in the activation of Ste7p (Fig. 2) (1, 60, 63).
Alanine substitutions at Ser-218 and Ser-222 of mammalian
MEK were generated by site-directed mutagenesis and con-
firmed the essential role of these regulatory sites in determin-
ing the catalytic activity of MEK (1, 6, 35, 41, 49, 63). Addi-
tionally, glutamate or aspartate substitutions that can mimic
phosphorylated residues were made at these positions in Mek1.
The resulting variants have constitutive catalytic activity and
promoted proliferation and differentiation responses associ-
ated with MEK-dependent signal pathways (6, 35, 41, 49).
Such a mutagenic approach opens a promising avenue for
dissecting the physiological responses of mammalian cells as-
sociated with MEK isoforms. This challenge will become more
daunting given the likely prospect that there will be many
mammalian MEK isoforms and that these will be involved in a
plethora of cellular processes. To know what constraints may
apply to this approach, we still need a better understanding of
the signal thresholds that trigger different pathway responses
and of the parameters that determine the fidelity of signal
transmission.
Toward this end, we sought to identify and characterize
mutations in the yeast Ste7p and Mkk1p MEK family members
that stimulate biological responses in the absence of inductive
signal. We uncovered such mutations and took advantage of
them to define the levels of MEK activity needed for different
biological responses. These analyses led us to unanticipated
but important insights into parameters that limit a given
MEK’s ability to cross-function in other MAPK activation
pathways.
MATERIALS AND METHODS
Plasmids. Two reporter gene constructs for targeted integration in S. cerevisiae
were made for the purpose of monitoring activity of the mating response path-
way. Plasmid pDH17 is a pRS306 (integrating URA3)-based vector that contains
the mfa2::FUS1-lacZ allele (51). This allele includes the 6.7-kb PstI-SalI frag-
ment containing the FUS1-lacZ reporter gene from pSL553 flanked by 2.1 kb of
MFa2 59 noncoding sequences which extend upstream from the SphI site spec-
ified in pSM23 and a 550-bp BamHI-EcoRI fragment containing MFa2 39 non-
coding sequences (19, 38). Plasmid pDH106 is a YIp5-based plasmid that con-
tains the HIS3::FUS1::HIS3 allele, which can be targeted to integrate at the HIS3
locus (55). In this allele, a 2.5-kb EcoRI-BstBI fragment containing HIS3 59
noncoding sequences flanks 1.2 kb of FUS1 promoter sequences fused 22 bp
upstream of the HIS3 coding region. The fusion junction between the FUS1
promoter and HIS3 coding sequences is identical to that described by Stevenson
et al. (54).
Several plasmids that carry MKK1 or STE7 alleles were used in this study.
Plasmid pSPC32 has the 1.9-kb BamHI-PstI fragment encompassing the MKK1
promoter and coding sequence inserted in the low-copy (CEN4 URA3) vector
YCplac33 (18, 24). Plasmid pSPC32-39 is identical to pSPC32 except for the
single base substitution that generated the MKK1-P368 allele (see below). Plas-
mid pSTE7.2 is a genomic library isolate that carries a 1.9-kb STE7 fragment in
the high-copy (2mm LEU2) vector YRp7 (55, 56). Plasmids pNC110 and
pSL1951 carry a 2.1-kb HindIII fragment encompassing the STE7 promoter and
coding sequence inserted in the HindIII site of the low-copy (CEN4 URA3)
FIG. 1. MAPK-dependent signal transduction pathways in S. cerevisiae and in mammals. Evidence supporting the depicted organization of the cell integrity,
pheromone-dependent mating, and mammalian MAPK-dependent pathways has been reviewed or published recently (13, 37, 39, 47, 60). Homologous kinases are
indicated within boxes at equivalent tiers in the pathways. TNFa, tumor necrosis factor alpha.
FIG. 2. Gain-of-function variants of Ste7p and Mkk1p. The diagram repre-
sents the nonconserved regions (solid boxes) and the catalytic domain (open box)
of a generalized MEK. The roman numerals refer to the subdomains described
by Hanks and Quinn (20). The substituted residues that generated gain-of-
function variants of Ste7p are indicated above the diagram; the amino acid
residues in subdomains VII and VIII of Mkk1p, Ste7p, and Mek1 are aligned
below (7, 24, 56). The positions of sites in Sek1 or Mek1 that are phosphorylated
by Mekk1 or Raf are indicated by asterisks (p), and the positions of the substi-
tuted serine residues in Ste7p-P368 and Mkk1p-P386 are indicated by the arrow
(40, 41, 63).
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vectors YCp50 and pRS316, respectively (27, 51, 56). Plasmids pSL2002,
pSL2234, and pSL2233 are identical to pSL1951 except for the STE7-DY259,
STE7-P368, and STE7-Y464 alleles, respectively (see below). Plasmid pSL2267
was constructed by cloning a PstI-XhoI fragment from pSL2234 into the low-copy
(CEN4 TRP1) vector pRS314 (51).
To facilitate biochemical analysis of Ste7p-P368, a serine-to-proline mutation
was introduced into the CYC1-STE7M allele by site-directed mutagenesis of
pNC318 with the mutagenic oligonucleotide 59-GACATATAAGTGGNCGTT
CC-39 (28, 64). The resulting plasmid (pNC318-P368) expresses the substitution
protein fused to an 11-amino-acid Myc epitope at the C terminus (Ste7Mp-P368)
under the control of the CYC1 promoter. Plasmids pNC318, pNC318-P368, and
pNC318-R220, which are low-copy (CEN3 TRP1) plasmids, were used for ex-
pression of Ste7Mp, Ste7Mp-P368, and Ste7Mp-R220, respectively, in yeast cells
(64). Plasmid pGA1944 was used to express the glutathione S-transferase (GST)-
Fus3p-R42 fusion in Escherichia coli (12).
Yeast strains and growth conditions. The genotypes of the yeast strains used
in this study are given in Table 1. Strains with different mutations in the cell
integrity pathway have been described before or were constructed by standard
yeast genetic procedures. Strain SYT32L-2C (pkc1ts mkk1D::LEU2) is a meiotic
segregant of a cross between strains SYT11-12A and 3233-1A. Diploid strain
3233-1B-D14 (MATa/MATa mkk1D::LEU2/mkk1D::LEU2 mkk2D::HIS3/
mkk2D::HIS3) was constructed by mating strains 3233-1B and 3233-4A. Strain
DL251-1B (bck1D::URA3) is a meiotic segregant of strain DL251 (31). Strain
SC3-590D (bck1D::URA3 ste5::LEU2) is a meiotic segregant of a derivative of
strain DL247 that had been made heterozygous for ste5::LEU2 by gene replace-
ment (see below).
Strain SY2003, which contains the HIS3::FUS1::HIS3 and mfa2::FUS1-lacZ
alleles integrated at the corresponding HIS3 and MFa2 loci, is a derivative of
Sc252 (59). The alleles were introduced by two-step gene replacements with
NheI-linearized pDH106 and HindIII-linearized pDH17, respectively. A far1
allele was introduced into a MATa strain of the Sc252 background by selecting
for a spontaneous mutation that caused the far1 mutant phenotype and then
verifying that the mutation belonged to the expected complementation group
(22). This far1 allele was introduced into theMATa progenitor of strains SY2068
and SY2071 by appropriate crosses.
Strain SY2074, a homozygous MATa/MATa FUS1::HIS3/FUS1::HIS3 FUS1-
lacZ/FUS1-lacZ ste4D::LEU2/ste4D::LEU2 diploid, was created by the following
steps. First, FUS1-lacZ ste4D::LEU2 haploid strains of opposite mating types
(SY2071 and SY2072) were transformed with YCpSTE4 to complement the
ste4Dmutation. The two strains were then crossed to give aMATa/MATa diploid
strain that is His2 as a result of cell type-specific repression of regulatory genes
required for FUS1 promoter activity. Finally, mating type-homozygous diploid
cells were selected as cells that spontaneously converted one or the other MAT
allele. Because the FUS1 promoter is active in diploid cells that are homozygous
at theMAT locus and wild type for other components of the pheromone response
signal pathway, the spontaneous convertants were easily identified as His1 cells
on medium lacking histidine and uracil. The mating phenotype of the resulting
His1 colonies was determined by the pheromone halo assay (53). Finally, an
isolate with an a phenotype was cured of the YCpSTE4 plasmid, which carries
the URA3 selectable marker, by being passaged on medium containing 5-fluoro-
orotic acid (2).
The strains with deletions of different components of the mating response
pathway were constructed by gene replacement (46). Plasmids p121 (ste4D::
LEU2 [M. Whiteway, Biotechnology Research Institute, Montreal, Quebec, Can-
ada]), pJM41 (ste5::LEU2 [G. Ammerer, University of Vienna, Vienna, Aus-
tria]), pSL1094 (ste11::URA3 [54]), pNC113 (ste7D3::LEU2 [4]), pSL2077 (ste7::
URA3 [54]), pEE98 (fus3-D6::LEU2 [10]), pBC65 (kss1D::URA3 [5]), and pVZ77
(bar1D::LEU2 [V. MacKay, Zymogenetics]) were the sources of the fragments
for the indicated gene replacements.
Unless otherwise specified, we used the media and genetic procedures de-
scribed by Sherman et al. (50). When derepression of the CYC1-STE7 alleles was
needed, 1% sucrose was used as the carbon source in place of glucose. Yeast
strains were transformed by the procedure of Ito et al. (25). Osmotic suppression
of temperature-dependent cell lysis was assayed essentially as described by Irie et
al. (24). b-Galactosidase activity was measured as described by Jarvis et al. (26).
For pheromone induction, BAR1 cultures were exposed to 5 mM a-factor for 75
min, and bar1 cultures were exposed to 50 nM a-factor for 75 min.
Isolation ofMKK1 and STE7 gain-of-function alleles. Yeast strain SYT32L-2C
was transformed with a CEN plasmid (pSPC32) that expresses the MKK1 gene
under the control of its own promoter and contains the URA3 gene as a select-
able marker. Spontaneously arising yeast transformants that grew at 378C, the
restrictive temperature for the conditional pkc1 allele (stt1-1), were selected for
further analysis (61). The dependence of the phenotype on the MKK1 plasmid
was scored as the inability to grow at the restrictive temperature in the presence
of 5-fluoro-orotic acid (2). Plasmid DNA was isolated from these transformants
and retransformed into a naive SYT32L-2C strain. The resulting transformants
were retested to confirm plasmid-dependent growth at the restrictive tempera-
TABLE 1. Yeast strains
Strain Relevant genotype Source or reference
SYT11-12A MATa stt1-1 (pkc1ts) ade8 his3 leu2 met3 ura3 61
SYT32L-2C MATa stt1-1 (pkc1ts) mkk1D::LEU2 his3 leu2 trp1 ura3 K. Irie
KAN-4C MATa bck1D::LEU2 ura3 leu2 trp1 24
3233-1A MATa mkk1D::LEU2 his3 leu2 trp1 ura3 24
3233-1B MATa mkk1D::LEU2 mkk2D::HIS3 his3 leu2 trp1 ura3 24
3233-4A MATa mkk1D::LEU2 mkk2D::HIS3 his3 leu2 trp1 ura3 24
3233-1B-D14 MATa mkk1D::LEU2 mkk2D::HIS3 his3 leu2 trp1 ura3 K. Irie
MATa mkk1D::LEU2 mkk2D::HIS3 his3 leu2 trp1 ura3
DL247a MATa bck1D::URA3 can1 his4 leu2-3,112 trp1-1 ura3-52 31
MATa BCK1 can1 his4 leu2-3,112 trp1-1 ura3-52
DL251-1Ba MATa bck1D::URA3 can1 his4 leu2-3,112 trp1-1 ura3-52 R. Cade and B. Errede
DL376a MATa pkc1D::LEU2 can1 his4 leu2-3,112 trp1-1 ura3-52 32
DL456a MATa mpk1D::TRP1 can1 his4 leu2-3,112 trp1-1 ura3-52 30
MATa mpk1D::TRP1 can1 his4 leu2-3,112 trp1-1 ura3-52
SC3-590Da MATa bck1D::URA3 ste5D::LEU2 can1 his4 leu2-3,112 trp1-1 ura3-52 B. Yashar
SY2003b MATa HIS3::FUS1::HIS3 mfa2-D1::FUS1-lacZ ade1 leu2-3,112 trp1-DH1 ura3-52 J. Horecka and G. Sprague
SY2068b MATa HIS3::FUS1::HIS3 mfa2-D1::FUS1-lacZ ade1 leu2-3,112 trp1-DH1 ura3-52 ste7D3::LEU2 far1 J. Printen
SY2071b MATa HIS3::FUS1::HIS3 mfa2-D1::FUS1-lacZ ade1 leu2-3,112 trp1-DH1 ura3-52 ste4D::LEU2 far1
SY2072b MATa HIS3::FUS1::HIS3 mfa2-D1::FUS1-lacZ ade1 leu2-3,112 trp1-DH1 ura3-52 ste4D::LEU2 far1 arg4
SY2074b MATa HIS3::FUS1::HIS3 mfa2-D1::FUS1-lacZ ade1 leu2-3,112 trp1-DH1 ura3-52 ste4D::LEU2 far1 arg4
MATa HIS3::FUS1::HIS3 mfa2-D1::FUS1-lacZ ade1 leu2-3,112 trp1-DH1 ura3-52 ste4D::LEU2 far1 ARG4
SY2186b MATa HIS3::FUS1::HIS3 mfa2-D1::FUS1-lacZ ade1 leu2-3,112 trp1-DH1 ura3-52 ste5D::LEU2
SY2208b MATa HIS3::FUS1::HIS3 mfa2-D1::FUS1-lacZ ade1 leu2-3,112 trp1-DH1 ura3-52 fus3D6::LEU2 kss1D::URA3 J. Horecka and G. Sprague
SY2263b MATa HIS3::FUS1::HIS3 mfa2-D1::FUS1-lacZ ade1 leu2-3,112 trp1-DH1 ura3-52 ste11D::ura3 J. Printen
SY2595b MATa HIS3::FUS1::HIS3 mfa2-D1::FUS1-lacZ ade1 leu2-3,112 trp1-DH1 ura3-52 ste4D
SY2810b MATa HIS3::FUS1::HIS3 mfa2-D1::FUS1-lacZ ade1 leu2-3,112 trp1-DH1 ura3-52 ste7::ura3
E929-6C-20c MATa cyc1 CYC7-H2 can1 leu2-3,112 trp1-D1 ura3-52 ste11D6 45
E929-6C-22c MATa cyc1 CYC7-H2 can1 leu2-3,112 trp1-D1 ura3-52 bar1D::LEU2 64
E929-6C-24c MATa cyc1 CYC7-H2 can1 leu2-3,112 trp1-D1 ura3-52 bar1D::LEU2 ste11D6 C. Adler and B. Errede
a Isogenic with strain EG123.
b Isogenic with strain Sc252.
c Isogenic with strain E929-6C.
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ture. The DNA sequence of MKK1 within pSPC32-39 was determined on both
strands (48).
Mutations in STE7 were generated by passage of plasmid pSL1951 through an
E. coli mutD strain (SB61) (15). A MATa/MATa ste4D/ste4D diploid strain
(SY2074) was transformed with a DNA preparation made from a single colony.
We used the a/a diploid in the selection scheme because recessive suppressors
that stimulate the FUS1::HIS3 reporter independently of the pheromone re-
sponse pathway were recovered at a high frequency in a haploid ste4D strain.
Transformants that grew on SD medium lacking uracil and histidine after 3 days
at 308C were recovered and tested for pheromone production as an independent
measure of pathway activation. The dependence of the phenotype on the plasmid
was tested by restreaking individual transformants onto medium containing
5-fluoro-orotic acid to select for plasmid loss. The resulting colonies were then
scored for the inability to grow on medium lacking histidine. Plasmids were
rescued from isolates that scored positively on the two secondary screens and
retested in a naive SY2074 strain. The DNA sequence of the entire STE7 coding
region was determined for all gain-of-function alleles (48). Plasmids containing
the mutant STE7 alleles were designated pSL2002 (STE7-DY259), pSL2234
(STE7-P368), and pSL2233 (STE7-Y464).
Immune complex kinase assays. In vitro assays of Ste7 catalytic activity mea-
sure phosphotransfer of g-32P from ATP to the protein substrate Fus3p. These
assays were performed directly on immune complexes of Ste7Mp isolated from
native protein extracts as described by Errede et al. (12). The polypeptide
substrate was a catalytically inactive form of Fus3p (Fus3Mp-R42) prepared from
a GST fusion protein produced in E. coli. The fusion protein was isolated on
glutathione-agarose columns and treated with thrombin to release the GST
polypeptide as described elsewhere (12, 52). The resulting mixture was used as
the substrate preparation without further purification. Typically, the thrombin
cleavage reaction does not go to completion, and the mixture consists of some
fusion protein in addition to the cleaved Fus3p-R42 and GST polypeptides.
Kinase assays were performed directly with the Ste7p immune complex bound
to protein A-Sepharose beads. For each reaction, immune complex beads (15 ml
packed volume) were suspended in 6 ml of kinase assay buffer (25 mM HEPES
[N-2-hydroxyethylpiperazine-N9-2-ethanesulfonic acid, pH 7.2], 15 mMMgCl2, 5
mM EGTA [ethylene glycol tetraacetic acid], 1 mM dithiothreitol, 0.1 mM
sodium orthovanadate, 15 mM 4-nitrophenylphosphate, 1 mM phenylmethylsul-
fonyl fluoride [PMSF], 20 mg of leupeptin per ml, 40 mg of aprotinin per ml).
Approximately 250 ng of the thrombin-treated GST-FusMp-R42 substrate (2 to
5 ml) was added to the above suspension. The reactions were initiated by addition
of an ATP mix (1 ml of 250 mM HEPES [pH 7.2], 2.0 ml of 1 mM ATP, 0.2 ml
of [g-32P]ATP [10 mCi/ml], 2.4 ml of 100 mM MgCl2) and water to give a final
reaction volume of 20 ml. The mixtures were incubated at 378C for 20 min, and
reactions were terminated by addition of an equal volume of 23 sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) buffer and boiling for 3
min (29). The resulting mixture of immune complex and substrate proteins was
resolved by SDS-PAGE (29). Incorporation of 32P into protein substrate was
quantified by PhosphorImager analysis of the Fus3p-R42 polypeptide band in the
dried gels.
Immunoblot analysis. Protein extracts for immunoblot analyses were fraction-
ated on SDS–7.5% polyacrylamide gels and transferred to nitrocellulose mem-
branes. The Myc1-9E10 monoclonal antibody (2 mg/ml) was used as the primary
antibody to detect Ste7M and Ste7M variant proteins on the nitrocellulose
membranes (14, 64). The Promega Protoblot immunoblot system with goat
anti-mouse immunoglobulin G conjugated to alkaline phosphatase (0.1 mg/ml)
was used to detect the primary antibody by colorimetric methods as described by
the vendor (Promega).
RESULTS
Identification ofMKK1 gain-of-function mutations.Gain-of-
function variants of Mkk1p were identified by screening for
spontaneous MKK1 mutations that suppress the cell lysis phe-
notype associated with loss of PKC1 function in the cell integ-
rity pathway (Fig. 1) (24, 61). A pkc1ts mkk1D::LEU2 yeast
strain (SYT32L-2C) was transformed with a CEN plasmid con-
taining the MKK1 gene under the control of its own promoter
(pSPC32). While expression of MKK1 from a high-copy-num-
ber (2mm) plasmid suppresses the cell lysis defect at the re-
strictive temperature for pkc1ts function (378C), single-copy
expression of wild-type MKK1 (pSPC32) does not (24). DNA
sequence analysis of the plasmid recovered from one of the
yeast transformants that grew at the restrictive temperature
(pSPC32-39) revealed a single-base-pair change in the MKK1
coding sequence. This mutation at position 1156 of the nucle-
otide sequence generates a serine-to-proline substitution at
amino acid 386 in Mkk1p (24). The mutant allele was desig-
nated MKK1-P386.
To further characterize the activity of Mkk1p-P386 in the cell
integrity pathway, the variant was expressed in strains contain-
ing deletions of different components in this pathway (Fig. 1).
While PKC1 function is essential for cell wall integrity and
growth, the cell lysis phenotype associated with loss of function
of BCK1, MKK1, and MKK2 or MPK1 is conditional (24, 30–
32). Strains containing deletions of these genes were trans-
formed with CEN plasmids expressing either Mkk1p or
Mkk1p-P386 and tested for growth at the nonpermissive tem-
perature of 378C. As expected from known epistatic relation-
ships, the ability of the Mkk1p-P386 variant to rescue the cell
lysis defect of different pathway mutants is dependent on the
downstream MAPK (Mpk1p) and independent of activation
events catalyzed by kinases that function upstream of Mkk1p
and Mkk2p (Table 2). On the basis of this pattern of suppres-
sion, Mkk1p-P386 constitutively activates the cell integrity path-
way.
Identification of STE7 gain-of-function mutations. Gain-of-
function STE7 alleles were identified by a screen for isolates
that could activate mating pathway transcriptional responses
independently of the G protein. This screen relied on a FUS1::
HIS3 reporter gene in which the well-characterized phero-
mone-inducible FUS1 promoter drives expression of the HIS3
coding region (54). Expression of His3p from this promoter is
dependent on the integrity of the pheromone response path-
way. In uninduced wild-type cells, the basal activity of the
pathway is sufficient to allow FUS1::HIS3 yeast strains to grow
on medium lacking histidine. Deletion of the G protein b
subunit (ste4D) eliminates this basal activity and renders cells
unable to grow on medium lacking histidine.
A mutagenized bank of STE7 plasmids was transformed into
a ste4D FUS1::HIS3 strain (SY2074), and individual transfor-
mants were screened for growth on medium lacking histidine.
This screen identified three independent STE7 plasmid alleles
(Fig. 2). Two alleles involved single-base-pair mutations that
produced a serine-to-proline substitution at amino acid residue
368 and an asparagine-to-tyrosine substitution at amino acid
residue 464. The third allele involved a deletion of three nucle-
otides, causing a loss of tyrosine residue 259. The mutant
alleles were named STE7-P368, STE7-Y464, and STE7-DY259,
respectively.
To characterize the activities of the Ste7p variants in the
mating response pathway, we transformed plasmids express-
ing Ste7p, Ste7p-P368, Ste7p-Y464, or Ste7p-DY259 into FUS1::
HIS3 strains from which different pheromone response path-
way components had been deleted. The transformed strains
were then tested for growth on medium lacking histidine. As
expected from the known relationship of pathway components,
the three mutant alleles but not the wild type suppressed the
transcriptional defect of the ste4D and ste5D strains but not of
the fus3D kss1D strain (Table 3). Unexpectedly, none of the
alleles supported FUS1-HIS3 expression in the ste11D strain,
which lacks the MEKK of this pathway. This result suggests
TABLE 2. Activity of MKK1 alleles in the
cell integrity pathwaya
Strain Relevant genotype
Growth on YPD at 378C
MKK1 MKK1-P386
DL376 pkc1D 2 1
KAN-4C bck1D 2 1
3233-1B mkk1D mkk2D 1 1
DL456 mpk1D 2 2
a The plasmids used were pSPC32 (MKK1) and pSPC32-39 (MKK1-P386).
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that the variants are not fully constitutive enzymes but still
depend on phosphorylation for their activity.
A more quantitative comparison of pathway activation pro-
moted by the three variants was obtained by measuring b-ga-
lactosidase activity expressed from a FUS1-lacZ reporter gene
in a ste7D strain. In the absence of inducer, the Ste7p variants
elevated b-galactosidase activity 2.4- to 6.6-fold over the amount
in the strain expressing wild-type Ste7p (Table 4). Of the three
variants, Ste7p-P368 promoted the highest basal activity, but
this amount was still threefold less than the amount found
under fully induced conditions with the wild-type enzyme. Af-
ter pheromone induction, the amount of b-galactosidase activ-
ity supported by all three variants was the same (Table 4).
These data show that the activity of the variants is still respon-
sive to the inductive signal.
Additionally, even the most potent of the gain-of-function
variants does not induce G1 arrest in the absence of phero-
mone or cause supersensitivity to pheromone. Wild-type cells
that are capable of G1 arrest (FAR1) and express Ste7p-P
368
have the same doubling time in the absence of pheromone as
strains expressing Ste7p (data not shown). Therefore, progres-
sion through the cell cycle does not appear to be perturbed by
expression of the Ste7p variant. Furthermore, Ste7p-P368 and
Ste7p strains respond identically in halo assays, which are one
measure of the G1 arrest response to pheromone (data not
shown).
Pheromone-independent activity of Ste7p-P368 is greater
than that of the wild-type enzyme. Alignment of the Ste7p and
Mkk1p protein sequences revealed that the substitutions in
Mkk1p-P386 and Ste7p-P368 had changed analogous serine res-
idues. This serine is positioned between the conserved kinase
subdomains VII and VIII in a region that is highly conserved
between members of the MEK family (Fig. 2). Because of this
striking outcome, we reasoned that an analysis of the enzy-
matic properties of Ste7p-P368 would yield information perti-
nent to the analogous substitution in other MEK family mem-
bers.
To express Ste7p-P368 for immune complex kinase assays, we
cloned the STE7-P368 allele into a yeast expression vector that
overproduced the protein under the control of the CYC1 pro-
moter and in frame with a c-Myc epitope tag (64). The result-
ing Ste7Mp-P368 variant was isolated from cell extracts by
immunoprecipitation and tested for the ability to phosphory-
late catalytically inactive Fus3p-R42 purified from E. coli as a
GST fusion (12). For reference, immune complex kinases as-
says were also performed with the wild-type Ste7Mp and cat-
alytically inactive Ste7Mp-R220 enzymes.
Phosphorylation of Fus3p-R42 was readily detected in the
immune complex kinase assays with Ste7Mp-P368 isolated from
uninduced cells (Fig. 3A, lane 3). Phosphorylation of the sub-
strate by Ste7Mp was weaker but could be detected by using
the more sensitive PhosphorImager analysis (results not shown).
Quantification of the PhosphorImager signals revealed that when
the enzymes were isolated from uninduced cells, there was
sixfold greater Fus3p-R42 phosphorylation with Ste7Mp-P368
than with wild-type Ste7Mp. Pheromone induction increased
the activities of both Ste7Mp-P368 and Ste7Mp, so that each
phosphorylated equivalent amounts of Fus3p-R42 (Fig. 3A,
lanes 5 and 6). Because the reactions are within the linear
range for the substrate, this result shows that under inducing
conditions, the two enzyme preparations have the same activ-
ity.
TABLE 3. Characterization of STE7 gain-of-function





Growth on medium lacking histidine
STE7 STE7-DY259 STE7-P368 STE7-Y464
SY2074 ste4D 2 1 1 1
SY2186 ste5D 2 1 1 1
SY2263 ste11D 2 2 2 2
SY2068 ste7D 1 1 1 1
SY2208 fus3D kss1D 2 2 2 2
a The plasmids used were pSL1951 (STE7), pSL2002 (STE7-DY259), pSL2234
(STE7-P368), and pSL2233 (STE7-Y464).







Without a-factor With a-factor
pRS316 None 1 2
pSL1951 STE7 5 98
pSL2002 STE7-DY259 12 101
pSL2234 STE7-P368 33 104
pSL2233 STE7-Y464 17 97
a Activities are expressed in modified Miller units (25).
FIG. 3. Comparison of Ste7p and Ste7p-P368 enzyme activities. (A) Immune
complex kinase assays comparing the amount of Fus3p-R42 phosphorylation
catalyzed by Ste7p (WT), Ste7p-P368 (P368), and Ste7p-R220 (R220). These pro-
teins were expressed in wild-type (E929-6C-22) and ste11D (E929-6C-24) yeast
strains, as indicated. Cultures were induced by mating pheromone (1) or not
induced (2) prior to extract preparation. To visualize 32Pi incorporation into
Fus3p-R42 by autoradiography, the panel showing assays of ste11D extracts was
overexposed compared with the wild-type panel. The radioactivity incorporated
into Fus3p-R42 in each lane was quantified by PhosphorImager analysis and is
reported below the autoradiogram as a percentage of the value measured for the
pheromone-induced Ste7p (WT) reaction (lane 5). Other phosphoproteins
(lanes 5 and 6) are residual GST-Fus3p-R42 fusion protein in the substrate
preparation (see text) and Ste7p, as indicated. This pheromone-induced and
Ste7p-dependent phosphorylation is attributed to Fus3p and Kss1p, which co-
immunoprecipitate with Ste7p (3). (B) Immunoblot detection of Ste7Mp-R220,
Ste7Mp, and Ste7Mp-P368 in extracts from wild-type and ste11D yeast cells. The
hyperphosphorylated (arrow) and less phosphorylated (asterisk) forms of Ste7p
are indicated.
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From the immunoblot analyses, increased production of
Ste7p-P368 does not cause the difference in basal activity found
for Ste7p and Ste7p-P368 (Fig. 3B, lanes 2 and 3). Additionally,
Coomassie staining patterns for the SDS-PAGE-fractionated
assay samples confirmed that the amount of immune complex
in each was the same (data not shown). Therefore, the serine-
to-proline substitution in Ste7p-P368 leads to a more active
preparation under basal conditions than is seen with the wild-
type enzyme.
Because Ste7p-P368-dependent reporter gene activation in
vivo required Ste11p, we compared the activity of the variant in
the presence and absence of Ste11p. In cells with a deletion of
STE11 (ste11D), Ste7Mp-P368 phosphorylated Fus3p-R42, but
its activity was five- to sixfold lower than when isolated from
uninduced wild-type cells (Fig. 3A, compare lanes 3 and 9). In
assays with either the wild type (Ste7Mp) or the catalytically
inactive variant (Ste7Mp-R220), we detected no phosphoryla-
tion of Fus3p-R42 by either autoradiography or PhosphorIm-
ager analysis (Fig. 3A, lanes 7 and 8, and results not shown).
Thus, within the sensitivity limits of these assays, Ste11p is
absolutely required for the activity of the wild-type enzyme but
not Ste7p-P368. Because Ste7p-P368 did not suppress the tran-
scriptional defect of a ste11D FUS1::HIS3 strain, this amount of
Ste11p-independent Ste7p-P368 activity is insufficient to pro-
mote a transcriptional output from the mating pathway.
The immune complex kinase assays provided a measure of
the activity of Ste7p-P368 in vitro. To evaluate how these vari-
ations in activity affect signal transmission in vivo, we analyzed
the phosphorylation states of Ste7p-P368. In response to pher-
omone, Ste7p is hyperphosphorylated in a Fus3p- and Kss1p-
dependent reaction (64). Conversion of the protein from a less
phosphorylated to a hyperphosphorylated form requires both
activation of Ste7p by the inductive signal and Ste7p-promoted
activation of Fus3p or Kss1p (12, 64). Thus, changes in the
phosphorylation state of Ste7p serve as an internal monitor for
signal flow between Ste7p and Fus3p/Kss1p.
The hyperphosphorylated and less phosphorylated forms of
Ste7Mp and its variants were identified on immunoblots by
their characteristic mobilities on SDS-PAGE (Fig. 3B). The
migration patterns for Ste7p and Ste7p-R220 were as expected.
In uninduced wild-type cells, the majority of both proteins was
detected as a single band with an apparent molecular mass of
58 kDa (Fig. 3B, lanes 1 and 2). In contrast, the majority of
Ste7Mp-P368 appears as a doublet at a mobility of ;70 kDa,
which is characteristic of the hyperphosphorylated forms (Fig.
3B, lane 3). For reference, the proteins from pheromone-
induced cultures were examined, and all three were in the
hyperphosphorylated state (Fig. 3B, lanes 3 to 5). Therefore,
the increased basal activity of Ste7p-P368 is sufficient to gener-
ate enough active Fus3p and Kss1p in vivo so that all detect-
able Ste7p is maintained in the hyperphosphorylated state. In
extracts from ste11D cells, Ste7M, Ste7M-R220, and Ste7M-P368
were present only in the less phosphorylated form (Fig. 3B,
lanes 7 to 9). Thus, the Ste11p-independent activity of Ste7p-
P368 is below the threshold required to generate increased
steady-state amounts of active Fus3p and Kss1p in vivo.
Ste7p-P368 functions effectively in the cell integrity pathway
if it is overproduced. We previously reported that Ste7p-P368
but not Ste7p mediates Raf-dependent signaling in yeast cells
(23). This interaction with a heterologous MEK activator sug-
gested to us that the more active variant might have gained the
ability to stimulate responses associated with other yeast
MAPK activation pathways. To test this possibility, we assessed
Ste7p-P368 for function in the cell integrity pathway.
A strain in which the MKK1 and the MKK2 genes had been
deleted was transformed with yeast plasmids that expressed
either Ste7p-P368 or Ste7p. The resulting transformants were
tested for growth at the restrictive temperature (378C). No
suppression of the signal defect was detected when either pro-
tein was expressed from the STE7 promoter (Fig. 4A, STE7
and STE7-P368). When Ste7p-P368 was overproduced from the
CYC1 promoter, it suppressed the signal defect in mkk1D
mkk2D cells as effectively as Mkk1p-P386 (Fig. 4A, compare
CYC1-STE7-P368 and MKK1-P386). By contrast, when Ste7p
was similarly overproduced, it rescued only ;25% of the cell
population (Fig. 4A, CYC1-STE7). Because the amount of
protein affected the phenotype, we attribute this behavior to
higher plasmid copy number in a subset of individual cells. We
verified that suppression was dependent on the expressed
Ste7p or Ste7p-P368 by curing cells of the plasmids and con-
firming that the isolates lost their ability to grow at 378C (re-
sults not shown). Although both the wild type and Ste7p-P368
could act in the cell integrity pathway, the more effective sup-
pression by Ste7p-P368 suggests that the proline substitution
variant is more capable of pathway cross-reaction, perhaps
because of an overall increase in its enzymatic capacity.
Ste5p affects pathway specificity. Mkk1p-P386 suppressed
the signal defect associated with the loss of upstream compo-
nents in the cell integrity pathway. To determine if Ste7p-P368
activity in this pathway had equivalent characteristics, we com-
pared Ste7p and Ste7p-P368 for the ability to suppress the
signal defect associated with the loss of Bck1p. Neither Ste7p
or Ste7p-P368 suppressed the bck1D phenotype, even when
the proteins were overproduced (Fig. 4B, STE7, STE7-P368,
CYC1-STE7, and CYC1-STE7-P368). The lower activity of
Ste7p and Ste7p-P368 in the absence of MEKK modification
could be responsible for this failure. Alternatively, the avail-
ability for cross-reaction could be more compromised in this
circumstance because Ste7p or Ste7p-P368 is competing with
Mkk1p/Mkk2p for the Mpk1p substrate.
The mating response pathway component Ste5p is postu-
lated to be a scaffold that organizes the kinases into a complex
(3, 36, 44). Reasoning that in this capacity, Ste5p could limit
the amount of Ste7p or Ste7p-P368 available to function in an
alternative pathway, we determined if either protein would
suppress the cell lysis phenotype in a ste5D bck1D double mu-
tant strain (SC3-590D). We found that in this double mutant
strain, overproduction of Ste7p-P368 suppressed the signal de-
fect in the cell integrity pathway as effectively as Mkk1p-P386
(Fig. 4C, CYC1-STE7-P368 and MKK1-P386). More impor-
tantly, some suppression was seen even when Ste7p-P368 was
expressed from its own promoter (Fig. 4C, STE7-P368). Sup-
pression of the bck1D defect required the proline substitution
in Ste7p, because expression of the wild-type Ste7p in any
amount did not suppress cell lysis (Fig. 4C, STE7 and CYC1-
STE7). These results show that Ste7p-P368 functions in the cell
integrity pathway with the same characteristics as Mkk1p-P386.
Because this ability is restricted by the presence of Ste5p, we
further conclude that one of the roles of Ste5p is to limit
illegitimate interactions of Ste7p with other pathways.
DISCUSSION
Conformational model for the effects of the proline 368
substitution on Ste7p activity. Ste7p-P368 was identified in a
screen for random STE7 mutations that stimulate mating-spe-
cific transcriptional responses in the absence of the signal-
transducing Gb subunit. Without pheromone stimulation, the
activity of Ste7p-P368 is sixfold higher than that of the wild-type
enzyme, but this increased activity still depends on the up-
stream kinase Ste11p. Pheromone stimulation causes a further
increase in Ste7p-P368 activity to an amount equivalent to that
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of the fully activated Ste7p. Our interpretation of these results
is that Ste7p-P368 requires phosphorylation for catalytic activ-
ity, but compared with the wild-type enzyme, a greater fraction
of Ste7p-P368 is present in the modified and active forms under
basal conditions.
Recent insights derived from the crystal structure of ERK2
suggest some plausible models for how the proline substitution
might affect Ste7p in the way that we suggest (62). The regu-
latory Thr-183 and Tyr-185 sites of ERK2 are located within a
‘‘phosphorylation lip’’ that is part of a loop between protein
kinase subdomains VII and VIII. The unphosphorylated Tyr-
185 is buried in a hydrophobic pocket and is not readily acces-
sible for modification by MEK. Therefore, it has been pro-
posed that conformational changes must occur in the lip region
upon binding to MEK for catalysis and also to accommodate
the resulting phosphotyrosine side group.
Serine 368 of Ste7p lies within an analogous region between
subdomains VII and VIII in proximity to the phosphate accep-
tor residue(s) that becomes modified upon activation by
Ste11p (Fig. 2) (17, 40, 63). Assuming that a mechanism similar
to that for ERK2 applies to Ste7p, the serine-to-proline sub-
stitution could alter the conformation of the phosphorylation
lip in a way that makes the regulatory site(s) more accessible to
MEKKs (62). An alternative and not mutually exclusive model
for the increased basal activity of Ste7p-P368 is that the pro-
posed conformational alteration in the lip region causes the
variant to be more resistant to a deactivation event, such as
might be catalyzed by a phosphatase.
Regardless of the underlying mechanism, the proline substi-
tution does alleviate restrictions on Ste7p interactions with
heterologous MEK kinases, such as mammalian t-Raf. This
characteristic allowed us to reconstitute Raf-1-dependent sig-
nal transduction in yeast cells and link it to the output of a
convenient reporter gene (23). The genetic potential of this
reconstituted signal pathway has already been exploited and
led to the identification of Bmh1p, a 14-3-3 protein family
member, as one factor that stimulates Raf-1 activation by Ras
(23). Ste7p-P368 and analogous genetic strategies may be useful
in future applications to identify activators of other heterolo-
gous MEKKs.
Various levels of MEK activity trigger different pathway
responses.We correlated different levels of Ste7p activity with
the transcriptional and G1 arrest responses that contribute to
the establishment of mating competence. An amount of Ste7p
or Ste7p-P368 activity that is 2% of the fully induced enzyme
was insufficient to elicit either response. However, a sixfold
FIG. 4. Activity of Ste7p-P368 and Ste7p in the cell integrity pathway. Overnight cultures of mkk1D mkk2D (3233-1B-D14), bck1D (DL251-1B), and ste5D bck1D
(SC3-590D) yeast strains containing plasmids with the indicated alleles were grown in appropriate selective medium at 228C. Equal numbers of cells were spread onto
complete medium with 2% sucrose as the carbon source and incubated at 378C for 3 days. The plates either lacked (2) or contained 1 M sorbitol (1) as an osmotic
stabilizer to compensate for the cell wall deficiency of the mutant strains. (A) The plasmids used were pNC110 (STE7), pSL2234 (STE7-P368), pNC318 (CYC1-STE7),
pNC318-P368 (CYC1-STE7-P368), and pSPC32-39 (MKK1-P386). Note that each allele is carried on a low-copy centromeric vector. (B and C) The plasmids used were
the same as in panel A except that the high-copy 2mm plasmid pSTE7.2 (STE7) was used instead of pNC110.
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increase above this amount, such as occurred when Ste7p-P368
was coexpressed with the unstimulated form of Ste11p, sur-
passed the signal threshold for a transcriptional response, but
this activity, which is still only 12% of the fully induced
amount, did not cause G1 arrest. Either this amount of Ste7p
activity is below the signal threshold needed, or G1 arrest
requires a pheromone-dependent input from an as yet unde-
fined branch of the pathway. Alternatively, the persistent ele-
vated activity caused by Ste7-P368 could trigger an adaptive
response which counteracts the inhibitory effects of pathway
activity on cell cycle progression.
The only assay presently available for evaluating signal ac-
tivity in the cell integrity pathway does not give a quantitative
measure of the relative activities of Mkk1p-P386 and Mkk1p.
Yet it is clear that the variant has higher activity than the
wild-type protein, because even without overproduction,
Mkk1p-P386 suppresses the growth defects associated with loss
of upstream components in this pathway. From our findings
with Ste7p-P368, it would be surprising if the constitutive ac-
tivity of Mkk1p-P386 is comparable to that of the fully active
form. Instead, we expect that its modification by Bck1p is still
essential for full activation but that the simple growth assay
employed here does not discriminate between the two levels of
activity.
Superficially, the Mkk1p and Ste7p serine-to-proline vari-
ants might be thought to behave differently, because the
former compensates for a deficiency in its upstream MEKK
but the latter does not. Yet two observations suggest that this
difference reflects a difference in the sensitivities of the bioas-
say for cell integrity compared with those for mating and the
associated transcriptional and cell cycle arrest responses to
pheromone. First, biochemical assays show that Ste7p-P368
does have a low but detectable level of activity in the absence
of its upstream MEKK, Ste11p (Fig. 3). Yet this activity is
insufficient for mating differentiation responses. Second, the
Ste7p and Mkk1p variants have the same properties when
compared in similar bioassays. For example, even with over-
expression, neither Ste7p-P368 nor Mkk1p-P386 caused any de-
tectable mating differentiation responses in a ste11D back-
ground (data not shown), yet either gain-of-function variant
suppressed the cell lysis defect of a bck1D strain. These obser-
vations support the notion that a lower signal threshold is
needed to support cell integrity than is needed to promote
mating differentiation.
Parameters important for pathway specificity of MEK func-
tion. Through the analysis of yeast gain-of-function MEK mu-
tations, we gained some insights into the in vivo parameters
that are important for fidelity of signaling in MAPK activation
pathways. Specifically, Ste7p-P368 is more able than Ste7p to
compensate for deficiencies in the cell integrity pathway, yet
the illegitimate interactions did not occur unless Ste5p was
missing or Ste7p-P368 was overexpressed and presumably ex-
ceeded the amount of Ste5p. There are two plausible models to
account for this behavior. One is that Ste5p may be an impor-
tant element for feedback reactions that attenuate the activity
of Ste7p (12). Another is that the architecture of these path-
ways may be a key determinant of Ste7p specificity. Recent
work suggests that Ste5p provides a scaffold in the mating
response pathway that promotes interactions between Ste11p,
Ste7p, Fus3p, and Kss1p (3, 36, 44). This work suggested that
such a framework is important in facilitating both activating
and attenuating interactions between the kinases. Our studies
suggest that another function for this organization could be
minimizing Ste7p cross-interactions with other pathways.
Our results with Ste7-P368 have broad ramifications for the
use of gain-of-function MEK mutations in other systems. Re-
cent evidence makes it clear that multiple MAPK activation
pathways transduce signals from distinct stimuli in vertebrates
(8, 39, 47, 60). Because the architecture of MAPK activation
pathways ensured the specificity of MEK gain-of-function mu-
tations in S. cerevisiae, we anticipate that similar mechanisms
might maintain the specificity of signaling by newly identified
MEK family members. If this prediction is valid, expression of
gain-of-function MEK mutations in vertebrates offers a pow-
erful approach for dissecting the physiological responses linked
to separate pathways. However, one constraint is that the vari-
ant MEKs need to be expressed at normal levels. Otherwise,
overproduction of the enzyme may allow cross-pathway inter-
actions and lead to ambiguities in the interpretation of results.
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